These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8164782)

  • 21. Functional discrepancies between tumor necrosis factor and lymphotoxin alpha explained by trimer stability and distinct receptor interactions.
    Schuchmann M; Hess S; Bufler P; Brakebusch C; Wallach D; Porter A; Riethmüller G; Engelmann H
    Eur J Immunol; 1995 Aug; 25(8):2183-9. PubMed ID: 7664782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re-evaluation of the chemotactic activity of tumour necrosis factor for monocytes.
    Wang JM; Walter S; Mantovani A
    Immunology; 1990 Nov; 71(3):364-7. PubMed ID: 2269474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential roles of tumor necrosis factor-alpha and interferon-gamma in mouse hypermetabolic and anorectic responses induced by LPS.
    Arsenijevic D; Garcia I; Vesin C; Vesin D; Arsenijevic Y; Seydoux J; Girardier L; Ryffel B; Dulloo A; Richard D
    Eur Cytokine Netw; 2000 Dec; 11(4):662-8. PubMed ID: 11125311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TNF and viruses: multiple interrelationships.
    Rubin BY
    Immunol Ser; 1992; 56():331-40. PubMed ID: 1550867
    [No Abstract]   [Full Text] [Related]  

  • 25. Lymphotoxin and tumour necrosis factor as possible mediators of an inflammatory response.
    Ciba Found Symp; 1987; 131():185-91. PubMed ID: 3330010
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum adiponectin, TNF-α, IL-12p70, and IL-13 levels in multiple sclerosis and the effects of different therapy regimens.
    Musabak U; Demirkaya S; Genç G; Ilikci RS; Odabasi Z
    Neuroimmunomodulation; 2011; 18(1):57-66. PubMed ID: 20714168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. II. A novel CTL-produced cytotoxin that is antigenically distinct from tumor necrosis factor and alpha-lymphotoxin.
    Green LM; Reade JL; Ware CF; Devlin PE; Liang CM; Devlin JJ
    J Immunol; 1986 Dec; 137(11):3488-93. PubMed ID: 2431035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.
    Browning JL; Sizing ID; Lawton P; Bourdon PR; Rennert PD; Majeau GR; Ambrose CM; Hession C; Miatkowski K; Griffiths DA; Ngam-ek A; Meier W; Benjamin CD; Hochman PS
    J Immunol; 1997 Oct; 159(7):3288-98. PubMed ID: 9317127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphotoxin alpha and tumour necrosis factor are not required for control of parasite growth, but differentially regulate cytokine production during Plasmodium chabaudi chabaudi AS infection.
    Clark K; Kulk N; Amante F; Haque A; Engwerda C
    Parasite Immunol; 2007 Mar; 29(3):153-8. PubMed ID: 17266742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine regulation of tumor necrosis factor-alpha and -beta (lymphotoxin)-messenger RNA expression in human peripheral blood mononuclear cells.
    Kasid A; Director EP; Stovroff MC; Lotze MT; Rosenberg SA
    Cancer Res; 1990 Aug; 50(16):5072-6. PubMed ID: 1696166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Transcriptional regulation of TNF/LT locus in immune cells].
    Shebzukhov IuV; Kuprash DV
    Mol Biol (Mosk); 2011; 45(1):56-67. PubMed ID: 21485497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Function, molecular structure and gene expression regulation of tumor necrosis factor and lymphotoxin].
    Higashi N
    Nihon Rinsho; 1992 Aug; 50(8):1939-44. PubMed ID: 1331566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional effects of TNF and lymphotoxin alpha1beta2 on FDC-like cells.
    Husson H; Lugli SM; Ghia P; Cardoso A; Roth A; Brohmi K; Carideo EG; Choi YS; Browning J; Freedman AS
    Cell Immunol; 2000 Aug; 203(2):134-43. PubMed ID: 11006011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory demyelinating events following treatment with anti-tumor necrosis factor.
    Fromont A; De Seze J; Fleury MC; Maillefert JF; Moreau T
    Cytokine; 2009 Feb; 45(2):55-7. PubMed ID: 19109035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function.
    Wang J; Foster A; Chin R; Yu P; Sun Y; Wang Y; Pfeffer K; Fu YX
    Eur J Immunol; 2002 Jul; 32(7):1969-79. PubMed ID: 12115617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic immunomodulatory effects of interferon-beta1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis.
    Weber F; Polak T; Günther A; Kubuschok B; Janovskaja J; Bitsch A; Poser S; Rieckmann P
    Ann Neurol; 1998 Jul; 44(1):27-34. PubMed ID: 9667590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
    Warzocha K; Bienvenu J; Coiffier B; Salles G
    Eur Cytokine Netw; 1995; 6(2):83-96. PubMed ID: 7578992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis.
    Mokhtarian F; Shi Y; Shirazian D; Morgante L; Miller A; Grob D
    J Immunol; 1994 Jun; 152(12):6003-10. PubMed ID: 8207225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections.
    Olleros ML; Guler R; Vesin D; Parapanov R; Marchal G; Martinez-Soria E; Corazza N; Pache JC; Mueller C; Garcia I
    Am J Pathol; 2005 Apr; 166(4):1109-20. PubMed ID: 15793291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
    Andrews JS; Berger AE; Ware CF
    J Immunol; 1990 Apr; 144(7):2582-91. PubMed ID: 1969453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.